Author:
Ma Shuo,Kong Shan,Wang Feng,Ju Shaoqing
Abstract
AbstractTargeted treatment, which can specifically kill tumour cells without affecting normal cells, is a new approach for tumour therapy. However, tumour cells tend to acquire resistance to targeted drugs during treatment. Circular RNAs (circRNAs) are single-stranded RNA molecules with unique structures and important functions. With the development of RNA sequencing technology, circRNAs have been found to be widespread in tumour-resistant cells and to play important regulatory roles. In this review, we present the latest advances in circRNA research and summarize the various mechanisms underlying their regulation. Moreover, we review the role of circRNAs in the chemotherapeutic resistance of tumours and explore the clinical value of circRNA regulation in treating tumour resistance.
Funder
National Natural Science Foundation of China
Jiangsu Program for Young Medical Talents
Social Development Key Project in Jiangsu Province
Sixth Talent Peaks Project of Jiangsu Province
Chinese Post-doctoral Science Foundation
Jiangsu Innovation and Entrepreneurship Training Program for Undergraduates
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献